U.S. Pharmacist Weekly News Update
November 7, 2018

Kidney Health Endangered With Intensive BP, Cholesterol Lowering in T2D
Efforts to improve health in type 2 diabetes patients at elevated risk of heart disease could be having undesirable adverse effects, according to a new study. Find out why researchers caution against intensive glucose, blood pressure, and cholesterol lowering in this cohort.


Aspirin Alone Helps Prevent
Post-Knee Replacement
Blood Clots

Many blood-thinner prescriptions pharmacists fill for post-knee replacement patients might be unnecessary. New research suggests that OTC aspirin works just as well in most case. Here are the details.

Biomarkers Successfully Predict When Endometriosis Will Respond to Treatment
Progestin-based therapies such as oral contraceptives are often prescribed to relieve the painful symptoms of endometriosis. In some cases, however, the therapy is ineffective. Find out how biomarkers can help individualize treatment for the common condition affecting 10% of reproductive-age women.

Use of ACEIs to Lower Blood Pressure Linked to Higher Lung-Cancer Risk
Pharmacists who fill a lot of prescriptions for angiotensin converting enzyme inhibitor drugs (ACEIs) to lower blood pressure might be surprised to find out that the drugs modestly increase the risk for lung cancer. Here is why researchers are concerned that the relatively small effect could have significant impact.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App